Literature DB >> 7512967

O-glycosylation in hinge region of mouse immunoglobulin G2b.

H Kim1, Y Yamaguchi, K Masuda, C Matsunaga, K Yamamoto, T Irimura, N Takahashi, K Kato, Y Arata.   

Abstract

Mouse monoclonal immunoglobulin G2b (IgG2b) antibodies are known to contain two forms of the heavy chain that are different in susceptibility to the protease attack. In the present study, by use of an affinity column containing sialic acid-binding lectins from Maackia amurensis seeds, a mouse monoclonal IgG2b was successfully separated into three phenotypes, which are different in the degree of sialylation in the heavy chain. In the N-linked oligosaccharides from all of the IgG2b phenotypes, virtually no sialylation was detected. Elution profiles of the lysyl endopeptidase digestion products were compared for the three phenotypes. The peptides eluted at different retention times were subjected to fast atom bombardment-mass spectrometry and amino acid sequence analyses. It was revealed that approximately 40% of the heavy chain of the mouse IgG2b are O-glycosylated at Thr-221A in the hinge region, predominantly with a tetrasaccharide composed of GalNAc, Gal, and two N-glycolylneuraminic acid residues. We suggest that the O-glycosylation renders the hinge region resistant against the proteolyses of the heavy chain. A therapeutic significance of the O-glycosylation of IgG2b is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512967

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Weak protein interactions and pH- and temperature-dependent aggregation of human Fc1.

Authors:  Haixia Wu; Kristopher Truncali; Julie Ritchie; Rachel Kroe-Barrett; Sanjaya Singh; Anne S Robinson; Christopher J Roberts
Journal:  MAbs       Date:  2015-08-12       Impact factor: 5.857

2.  Characterization of mouse switch variant antibodies by matrix-assisted laser desorption ionization mass spectrometry and electrospray ionization mass spectrometry.

Authors:  S Akashi; K Noguchi; R Yuji; U Tagami; K Hirayama; K Kato; H Kim; K Tokioka; I Shimada; Y Arata
Journal:  J Am Soc Mass Spectrom       Date:  1996-08       Impact factor: 3.109

Review 3.  The acceptor specificity of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.

Authors:  A P Elhammer; F J Kézdy; A Kurosaka
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

Review 4.  Analysis of Mammalian O-Glycopeptides-We Have Made a Good Start, but There is a Long Way to Go.

Authors:  Zsuzsanna Darula; Katalin F Medzihradszky
Journal:  Mol Cell Proteomics       Date:  2017-11-21       Impact factor: 5.911

Review 5.  Biochemical and biophysical characterization of humanized IgG1 produced in Pichia pastoris.

Authors:  Sha Ha; Yang Wang; Richard R Rustandi
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

6.  Biological Insights into Therapeutic Protein Modifications throughout Trafficking and Their Biopharmaceutical Applications.

Authors:  Xiaotian Zhong; Jill F Wright
Journal:  Int J Cell Biol       Date:  2013-04-18

7.  Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT).

Authors:  R De Santis; A M Anastasi; V D'Alessio; A Pelliccia; C Albertoni; A Rosi; B Leoni; R Lindstedt; F Petronzelli; M Dani; A Verdoliva; A Ippolito; N Campanile; V Manfredi; A Esposito; G Cassani; M Chinol; G Paganelli; P Carminati
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

8.  Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3).

Authors:  Rosina Plomp; Gillian Dekkers; Yoann Rombouts; Remco Visser; Carolien A M Koeleman; Guinevere S M Kammeijer; Bas C Jansen; Theo Rispens; Paul J Hensbergen; Gestur Vidarsson; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2015-03-10       Impact factor: 5.911

Review 9.  Biomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applications.

Authors:  Paloma Juarez; Vikram Virdi; Ann Depicker; Diego Orzaez
Journal:  Plant Biotechnol J       Date:  2016-02-13       Impact factor: 9.803

10.  The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies.

Authors:  Melanie J Lewis; Bettina Wagner; Jenny M Woof
Journal:  Mol Immunol       Date:  2007-07-31       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.